Abstract: Disclosed herein is a method for transforming data for low volume transmission of a meta model based protocol which monitors power amount data of new renewable energy, including: generating energy sensing data; receiving, by a client, the energy sensing data and transforming the received energy sensing data into meta model data including a meta model and meta data; generating packet meta model data by dividing and compressing the meta model data; transmitting the packet meta model data to a server through an Internet of Things (IOT) communication network; and parsing, by the server, the packet meta model data to output the meta model data.

Abstract: A novel imidazopyridine derivative compound and uses thereof are disclosed.

Abstract: Disclosed herein is a method for transforming data for low volume transmission of a meta model based protocol which monitors power amount data of new renewable energy, including: generating energy sensing data; receiving, by a client, the energy sensing data and transforming the received energy sensing data into meta model data including a meta model and meta data; generating packet meta model data by dividing and compressing the meta model data; transmitting the packet meta model data to a server through an Internet of Things (IOT) communication network; and parsing, by the server, the packet meta model data to output the meta model data.

Abstract: The present invention relates to a novel heterocyclic derivative compound and a use thereof, and in particular, to a novel heterocyclic derivative compound having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the same preventing and treating various diseases relating to the FGFR.

Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

Abstract: Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).

Abstract: Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).

Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.